Christopher M. Gomez - Publications

University of Minnesota, Twin Cities, Minneapolis, MN 
Neuroscience Biology, Cell Biology

94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Xie T, Appelbaum D, Bernard J, Padmanaban M, Pu Y, Gomez C. Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6. Journal of Neurology. PMID 27544504 DOI: 10.1007/S00415-016-8261-6  0.72
2016 Miyazaki Y, Du X, Muramatsu S, Gomez CM. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron. Science Translational Medicine. 8: 347ra94. PMID 27412786 DOI: 10.1126/Scitranslmed.Aaf5660  0.72
2016 Shinnick JE, Schadt K, Strawser C, Wilcox N, Perlman SL, Wilmot GR, Gomez CM, Mathews KD, Yoon G, Zesiewicz T, Hoyle C, Subramony SH, Yiu EM, Delatycki MB, Brocht AF, et al. Comorbid Medical Conditions in Friedreich Ataxia: Association With Inflammatory Bowel Disease and Growth Hormone Deficiency. Journal of Child Neurology. PMID 27071470 DOI: 10.1177/0883073816643408  0.72
2016 Lungu OV, Bares M, Liu T, Gomez CM, Cechova I, Ashe J. Trial-to-trial Adaptation: Parsing out the Roles of Cerebellum and BG in Predictive Motor Timing. Journal of Cognitive Neuroscience. 1-15. PMID 26942317 DOI: 10.1162/Jocn_A_00943  0.72
2015 Brouillette AM, Öz G, Gomez CM. Cerebrospinal Fluid Biomarkers in Spinocerebellar Ataxia: A Pilot Study. Disease Markers. 2015: 413098. PMID 26265793 DOI: 10.1155/2015/413098  0.72
2015 Falcon MI, Gomez CM, Chen EE, Shereen A, Solodkin A. Early Cerebellar Network Shifting in Spinocerebellar Ataxia Type 6. Cerebral Cortex (New York, N.Y. : 1991). PMID 26209844 DOI: 10.1093/Cercor/Bhv154  0.72
2015 Gomez CM, Kawakami H. Neurogenetics: The expanding horizons of diagnosis and disease pathogenesis. Neurology. 84: 1070-1. PMID 25681450 DOI: 10.1212/Wnl.0000000000001372  0.72
2015 Lo RY, Figueroa KP, Pulst SM, Lin CY, Perlman S, Wilmot G, Gomez C, Schmahmann J, Paulson H, Shakkottai VG, Ying S, Zesiewicz T, Bushara K, Geschwind M, Xia G, et al. Coenzyme Q10 and spinocerebellar ataxias. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 214-20. PMID 25449974 DOI: 10.1002/Mds.26088  0.72
2015 Zhu H, Grajales-Reyes GE, Alicea-Vázquez V, Grajales-Reyes JG, Robinson K, Pytel P, Báez-Pagán CA, Lasalde-Dominicci JA, Gomez CM. Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome. Experimental Neurology. 270: 88-94. PMID 25448156 DOI: 10.1016/J.Expneurol.2014.10.008  0.72
2015 Hekman KE, Gomez CM. The autosomal dominant spinocerebellar ataxias: emerging mechanistic themes suggest pervasive Purkinje cell vulnerability. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 554-61. PMID 25136055 DOI: 10.1136/Jnnp-2014-308421  0.72
2014 Gomez CM, Das S. Clinical exome sequencing: the new standard in genetic diagnosis. Jama Neurology. 71: 1215-6. PMID 25133783 DOI: 10.1001/Jamaneurol.2014.2015  0.72
2014 Du X, Semler BL, Gomez CM. Revelations from a bicistronic calcium channel gene. Cell Cycle (Georgetown, Tex.). 13: 875-6. PMID 24552819 DOI: 10.4161/Cc.28199  0.72
2014 Zhu H, Pytel P, Gomez CM. Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome. Human Molecular Genetics. 23: 69-77. PMID 23943790 DOI: 10.1093/Hmg/Ddt397  0.72
2013 Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD, Ying SH, Zesiewicz TA, Paulson HL, Shakkottai VG, Bushara KO, Kuo SH, Geschwind MD, Xia G, Mazzoni P, et al. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet Journal of Rare Diseases. 8: 177. PMID 24225362 DOI: 10.1186/1750-1172-8-177  0.72
2013 Du X, Wang J, Zhu H, Rinaldo L, Lamar KM, Palmenberg AC, Hansel C, Gomez CM. Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6. Cell. 154: 118-33. PMID 23827678 DOI: 10.1016/J.Cell.2013.05.059  0.72
2013 Zhu H, Bhattacharyya BJ, Lin H, Gomez CM. Skeletal muscle calpain acts through nitric oxide and neural miRNAs to regulate acetylcholine release in motor nerve terminals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 7308-24. PMID 23616539 DOI: 10.1523/Jneurosci.0224-13.2013  0.72
2013 Grajales-Reyes GE, Báez-Pagán CA, Zhu H, Grajales-Reyes JG, Delgado-Vélez M, García-Beltrán WF, Luciano CA, Quesada O, Ramírez R, Gómez CM, Lasalde-Dominicci JA. Transgenic mouse model reveals an unsuspected role of the acetylcholine receptor in statin-induced neuromuscular adverse drug reactions. The Pharmacogenomics Journal. 13: 362-8. PMID 22688219 DOI: 10.1038/Tpj.2012.21  0.72
2012 Hekman KE, Yu GY, Brown CD, Zhu H, Du X, Gervin K, Undlien DE, Peterson A, Stevanin G, Clark HB, Pulst SM, Bird TD, White KP, Gomez CM. A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult. Human Molecular Genetics. 21: 5472-83. PMID 23001565 DOI: 10.1093/Hmg/Dds392  0.72
2012 Regner SR, Wilcox NS, Friedman LS, Seyer LA, Schadt KA, Brigatti KW, Perlman S, Delatycki M, Wilmot GR, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Ravina B, et al. Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. Journal of Child Neurology. 27: 1152-8. PMID 22752494 DOI: 10.1177/0883073812448462  0.72
2012 Evans-Galea MV, Carrodus N, Rowley SM, Corben LA, Tai G, Saffery R, Galati JC, Wong NC, Craig JM, Lynch DR, Regner SR, Brocht AF, Perlman SL, Bushara KO, Gomez CM, et al. FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Annals of Neurology. 71: 487-97. PMID 22522441 DOI: 10.1002/Ana.22671  0.72
2012 Zhu H, Gomez CM. Further evidence for the role of IP 3R 1 in regulating subsynaptic gene expression and neuromuscular transmission. Channels (Austin, Tex.). 6: 65-8. PMID 22418950 DOI: 10.4161/chan.19175  0.72
2012 Solodkin A, Gomez CM. Spinocerebellar ataxia type 6. Handbook of Clinical Neurology. 103: 461-73. PMID 21827907 DOI: 10.1016/B978-0-444-51892-7.00029-2  0.72
2012 Zhu H, Gomez CM. Further evidence for the role of IP3R1 in regulating subsynaptic gene expression and neuromuscular transmission Channels. 6. DOI: 10.4161/chan.6.1.19175  0.72
2011 Zhu H, Bhattacharyya BJ, Lin H, Gomez CM. Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 15269-83. PMID 22031873 DOI: 10.1523/Jneurosci.3766-11.2011  0.72
2011 Paciorkowski AR, Shafrir Y, Hrivnak J, Patterson MC, Tennison MB, Clark HB, Gomez CM. Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms. Neurology. 77: 1055-60. PMID 21880993 DOI: 10.1212/Wnl.0B013E31822E5627  0.4
2011 Pula JH, Towle VL, Staszak VM, Cao D, Bernard JT, Gomez CM. Retinal Nerve Fibre Layer and Macular Thinning in Spinocerebellar Ataxia and Cerebellar Multisystem Atrophy. Neuro-Ophthalmology (Aeolus Press). 35: 108-114. PMID 21866205 DOI: 10.3109/01658107.2011.580898  0.72
2011 Sidtis JJ, Ahn JS, Gomez C, Sidtis D. Speech characteristics associated with three genotypes of ataxia Journal of Communication Disorders. 44: 478-492. PMID 21592489 DOI: 10.1016/J.Jcomdis.2011.03.002  0.72
2011 Figueroa KP, Waters MF, Garibyan V, Bird TD, Gomez CM, Ranum LP, Minassian NA, Papazian DM, Pulst SM. Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia 13 (SCA13). Plos One. 6: e17811. PMID 21479265 DOI: 10.1371/Journal.Pone.0017811  0.72
2011 Bares M, Lungu OV, Liu T, Waechter T, Gomez CM, Ashe J. The neural substrate of predictive motor timing in spinocerebellar ataxia. Cerebellum (London, England). 10: 233-44. PMID 21110147 DOI: 10.1007/S12311-010-0237-Y  0.72
2011 Solodkin A, Peri E, Chen EE, Ben-Jacob E, Gomez CM. Loss of intrinsic organization of cerebellar networks in spinocerebellar ataxia type 1: correlates with disease severity and duration. Cerebellum (London, England). 10: 218-32. PMID 20886327 DOI: 10.1007/S12311-010-0214-5  0.72
2011 Oz G, Iltis I, Hutter D, Thomas W, Bushara KO, Gomez CM. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum (London, England). 10: 208-17. PMID 20838948 DOI: 10.1007/S12311-010-0213-6  0.72
2011 Sidtis JJ, Strother SC, Groshong A, Rottenberg DA, Gomez C. Corrigendum to " Longitudinal cerebral blood flow changes during speech in hereditary ataxia" [Brain & Language 114 (2010) 43-51] Brain and Language. 117: 100. DOI: 10.1016/J.Bandl.2011.03.003  0.72
2010 Pula JH, Gomez CM, Kattah JC. Ophthalmologic features of the common spinocerebellar ataxias. Current Opinion in Ophthalmology. 21: 447-53. PMID 20811282 DOI: 10.1097/Icu.0B013E32833Eaf71  0.72
2010 Iltis I, Hutter D, Bushara KO, Clark HB, Gross M, Eberly LE, Gomez CM, Oz G. (1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2. Brain Research. 1358: 200-10. PMID 20713024 DOI: 10.1016/J.Brainres.2010.08.030  0.72
2010 Sidtis JJ, Strother SC, Groshong A, Naoum A, Rottenberg DA, Gomez C. Longitudinal cerebral blood flow changes during speech in hereditary ataxia. Brain and Language. 114: 43-51. PMID 20417959 DOI: 10.1016/J.Bandl.2010.03.007  0.72
2010 Oz G, Hutter D, Tkác I, Clark HB, Gross MD, Jiang H, Eberly LE, Bushara KO, Gomez CM. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1253-61. PMID 20310029 DOI: 10.1002/Mds.23067  0.72
2010 Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 426-32. PMID 20063431 DOI: 10.1002/Mds.22912  0.72
2008 van der Knaap MS, Arts WF, Garbern JY, Hedlund G, Winkler F, Barbosa C, King MD, Bjørnstad A, Hussain N, Beyer MK, Gomez C, Patterson MC, Grattan-Smith P, Timmons M, van der Valk P. Cerebellar leukoencephalopathy: most likely histiocytosis-related. Neurology. 71: 1361-7. PMID 18936429 DOI: 10.1212/01.Wnl.0000327680.74910.93  0.72
2008 Watase K, Barrett CF, Miyazaki T, Ishiguro T, Ishikawa K, Hu Y, Unno T, Sun Y, Kasai S, Watanabe M, Gomez CM, Mizusawa H, Tsien RW, Zoghbi HY. Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels. Proceedings of the National Academy of Sciences of the United States of America. 105: 11987-92. PMID 18687887 DOI: 10.1073/Pnas.0804350105  0.72
2008 Epstein E, Farmer JM, Tsou A, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews K, Wilson RB, Balcer LJ, Lynch DR. Health related quality of life measures in Friedreich Ataxia. Journal of the Neurological Sciences. 272: 123-8. PMID 18571673 DOI: 10.1016/J.Jns.2008.05.009  0.72
2008 Christova P, Anderson JH, Gomez CM. Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. Archives of Neurology. 65: 530-6. PMID 18413478 DOI: 10.1001/Archneur.65.4.530  0.72
2008 Myers L, Farmer JM, Wilson RB, Friedman L, Tsou A, Perlman SL, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews KD, Balcer LJ, Lynch DR. Antioxidant use in Friedreich ataxia. Journal of the Neurological Sciences. 267: 174-6. PMID 17988688 DOI: 10.1016/J.Jns.2007.10.008  0.72
2007 Groshong JS, Spencer MJ, Bhattacharyya BJ, Kudryashova E, Vohra BP, Zayas R, Wollmann RL, Miller RJ, Gomez CM. Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome. The Journal of Clinical Investigation. 117: 2903-12. PMID 17853947 DOI: 10.1172/Jci30383  0.72
2007 Kordasiewicz HB, Gomez CM. Molecular pathogenesis of spinocerebellar ataxia type 6. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 4: 285-94. PMID 17395139 DOI: 10.1016/J.Nurt.2007.01.003  0.72
2007 Raike RS, Kordasiewicz HB, Thompson RM, Gomez CM. Dominant-negative suppression of Cav2.1 currents by alpha(1)2.1 truncations requires the conserved interaction domain for beta subunits. Molecular and Cellular Neurosciences. 34: 168-77. PMID 17161621 DOI: 10.1016/J.Mcn.2006.10.011  0.72
2007 Zayas R, Groshong JS, Gomez CM. Inositol-1,4,5-triphosphate receptors mediate activity-induced synaptic Ca2+ signals in muscle fibers and Ca2+ overload in slow-channel syndrome. Cell Calcium. 41: 343-52. PMID 16973214 DOI: 10.1016/J.Ceca.2006.07.007  0.72
2006 Zayas R, Lasalde-Dominicci J, Gomez CM. Macroscopic properties of spontaneous mutations in slow-channel syndrome: correlation by domain and disease severity. Synapse (New York, N.Y.). 60: 441-9. PMID 16881075 DOI: 10.1002/Syn.20317  0.72
2006 Vohra BP, Groshong JS, Zayas R, Wollmann RL, Gomez CM. Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model. Neurobiology of Disease. 23: 462-70. PMID 16815027 DOI: 10.1016/J.Nbd.2006.04.018  0.72
2006 Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology. 66: 1711-6. PMID 16769945 DOI: 10.1212/01.Wnl.0000218155.46739.90  0.72
2006 Maschke M, Gomez CM, Tuite PJ, Pickett K, Konczak J. Depth perception in cerebellar and basal ganglia disease. Experimental Brain Research. 175: 165-76. PMID 16733701 DOI: 10.1007/S00221-006-0535-2  0.72
2006 Howell MJ, Mahowald MW, Gomez CM. Evaluation of sleep and daytime somnolence in spinocerebellar ataxia type 6 (SCA6). Neurology. 66: 1430-1. PMID 16682680 DOI: 10.1212/01.Wnl.0000210485.37521.0B  0.72
2006 Navedo MF, Lasalde-Dominicci JA, Báez-Pagán CA, Díaz-Pérez L, Rojas LV, Maselli RA, Staub J, Schott K, Zayas R, Gomez CM. Novel beta subunit mutation causes a slow-channel syndrome by enhancing activation and decreasing the rate of agonist dissociation. Molecular and Cellular Neurosciences. 32: 82-90. PMID 16624571 DOI: 10.1016/J.Mcn.2006.02.004  0.72
2006 Kordasiewicz HB, Thompson RM, Clark HB, Gomez CM. C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity. Human Molecular Genetics. 15: 1587-99. PMID 16595610 DOI: 10.1093/Hmg/Ddl080  0.72
2006 Gomez CM. Translational Neuroscience: a Neurologist's translation. Current Neurology and Neuroscience Reports. 6: 85-7. PMID 16522259 DOI: 10.1007/S11910-996-0027-6  0.72
2006 Sidtis JJ, Gomez C, Groshong A, Strother SC, Rottenberg DA. Mapping cerebral blood flow during speech production in hereditary ataxia. Neuroimage. 31: 246-54. PMID 16443374 DOI: 10.1016/J.Neuroimage.2005.12.005  0.72
2005 Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, Taylor P, Wilson R, Ashizawa T. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale Neurology. 64: 1261-1262. PMID 15824358 DOI: 10.1212/01.Wnl.0000156802.15466.79  0.72
2004 Engel KC, Anderson JH, Gomez CM, Soechting JF. Deficits in ocular and manual tracking due to episodic ataxia type 2. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 778-87. PMID 15254935 DOI: 10.1002/Mds.20121  0.72
2004 Vohra BP, Groshong JS, Maselli RA, Verity MA, Wollmann RL, Gomez CM. Focal caspase activation underlies the endplate myopathy in slow-channel syndrome. Annals of Neurology. 55: 347-52. PMID 14991812 DOI: 10.1002/Ana.10823  0.72
2004 Bushara KO, Nance M, Gomez CM. Antigliadin antibodies in Huntington's disease. Neurology. 62: 132-3. PMID 14718716 DOI: 10.1212/Wnl.62.1.132  0.72
2004 Gomez CM. ARSACS goes global. Neurology. 62: 10-1. PMID 14718687 DOI: 10.1212/Wnl.62.1.10  0.72
2004 Maschke M, Gomez CM, Ebner TJ, Konczak J. Hereditary cerebellar ataxia progressively impairs force adaptation during goal-directed arm movements. Journal of Neurophysiology. 91: 230-8. PMID 13679403 DOI: 10.1152/Jn.00557.2003  0.72
2003 Subramony SH, Schott K, Raike RS, Callahan J, Langford LR, Christova PS, Anderson JH, Gomez CM. Novel CACNA1A mutation causes febrile episodic ataxia with interictal cerebellar deficits. Annals of Neurology. 54: 725-31. PMID 14681882 DOI: 10.1002/Ana.10756  0.32
2003 Gomez CM, Subramony SH. Dominantly inherited ataxias. Seminars in Pediatric Neurology. 10: 210-22. PMID 14653409 DOI: 10.1016/S1071-9091(03)00030-5  0.72
2003 Maschke M, Gomez CM, Tuite PJ, Konczak J. Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia. Brain : a Journal of Neurology. 126: 2312-22. PMID 12821507 DOI: 10.1093/Brain/Awg230  0.72
2003 Gomez CM. Spinocerebellar Ataxias Office Practice of Neurology: Second Edition. 783-798. DOI: 10.1016/B0-44-306557-8/50126-X  0.72
2002 Gomez CM, Maselli RA, Groshong J, Zayas R, Wollmann RL, Cens T, Charnet P. Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6447-57. PMID 12151524 DOI: 10.1523/Jneurosci.22-15-06447.2002  0.72
2002 Gomez CM, Maselli RA, Vohra BP, Navedo M, Stiles JR, Charnet P, Schott K, Rojas L, Keesey J, Verity A, Wollmann RW, Lasalde-Dominicci J. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms. Annals of Neurology. 51: 102-12. PMID 11782989 DOI: 10.1002/Ana.10077  0.72
2001 Maselli RA, Kong DZ, Bowe CM, McDonald CM, Ellis WG, Agius MA, Gomez CM, Richman DP, Wollmann RL. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology. 57: 279-89. PMID 11468313 DOI: 10.1212/Wnl.57.2.279  0.72
2001 Gomez CM. Polyglutamine aggregates in SCA6 Purkinje cells: A tail of two toxicities Neurology. 56: 1618-1619. PMID 11425924 DOI: 10.1212/Wnl.56.12.1618  0.72
2000 Restituito S, Thompson RM, Eliet J, Raike RS, Riedl M, Charnet P, Gomez CM. The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 6394-403. PMID 10964945 DOI: 10.1523/Jneurosci.20-17-06394.2000  0.72
1998 Moseley ML, Benzow KA, Schut LJ, Bird TD, Gomez CM, Barkhaus PE, Blindauer KA, Labuda M, Pandolfo M, Koob MD, Ranum LP. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology. 51: 1666-71. PMID 9855520 DOI: 10.1212/Wnl.51.6.1666  0.4
1998 Richman DP, Agius MA, Kirvan CA, Gomez CM, Fairclough RH, Dupont BL, Maselli RA. Antibody effector mechanisms in myasthenia gravis. The complement hypothesis. Annals of the New York Academy of Sciences. 841: 450-65. PMID 9668274 DOI: 10.1111/J.1749-6632.1998.Tb10962.X  0.72
1998 Gomez CM, Maselli R, Williams JM, Bhattacharyya BB, Wollmann RL, Day JW. Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome. Annals of the New York Academy of Sciences. 841: 167-80. PMID 9668235 DOI: 10.1111/J.1749-6632.1998.Tb10923.X  0.72
1998 Gouw LG, Castañeda MA, McKenna CK, Digre KB, Pulst SM, Perlman S, Lee MS, Gomez C, Fischbeck K, Gagnon D, Storey E, Bird T, Jeri FR, Ptácek LJ. Analysis of the dynamic mutation in the SCA7 gene shows marked parental effects on CAG repeat transmission. Human Molecular Genetics. 7: 525-32. PMID 9467013 DOI: 10.1093/Hmg/7.3.525  0.72
1997 Gomez CM, Thompson RM, Gammack JT, Perlman SL, Dobyns WB, Truwit CL, Zee DS, Clark HB, Anderson JH. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Annals of Neurology. 42: 933-50. PMID 9403487 DOI: 10.1002/Ana.410420616  0.72
1997 Bhattacharyya BJ, Day JW, Gundeck JE, Leonard S, Wollmann RL, Gomez CM. Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents. Synapse (New York, N.Y.). 27: 367-77. PMID 9372559 DOI: 10.1002/(Sici)1098-2396(199712)27:4<367::Aid-Syn10>3.0.Co;2-P  0.72
1997 Gomez CM, Maselli R, Gundeck JE, Chao M, Day JW, Tamamizu S, Lasalde JA, McNamee M, Wollmann RL. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4170-9. PMID 9151734 DOI: 10.1523/Jneurosci.17-11-04170.1997  0.72
1997 Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Hamida MB, Campanella G, Filla A, Schut L, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome Journal of the Neurological Sciences. 145: 205-211. PMID 9094050 DOI: 10.1016/S0022-510X(96)00231-6  0.72
1996 Gomez CM, Maselli R, Gammack J, Lasalde J, Tamamizu S, Cornblath DR, Lehar M, McNamee M, Kuncl RW. A β-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome Annals of Neurology. 39: 712-723. PMID 8651643 DOI: 10.1002/Ana.410390607  0.72
1996 Gomez CM, Bhattacharyya BB, Charnet P, Day JW, Labarca C, Wollmann RL, Lambert EH. A transgenic mouse model of the slow-channel syndrome. Muscle & Nerve. 19: 79-87. PMID 8538674 DOI: 10.1002/(Sici)1097-4598(199601)19:1<79::Aid-Mus11>3.0.Co;2-Z  0.72
1995 Gomez CM, Gammack JT. A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome Neurology. 45: 982-985. PMID 7538206 DOI: 10.1212/Wnl.45.5.982  0.4
1993 Richman DP, Wollmann RL, Maselli RA, Gomez CM, Corey AL, Agius MA, Fairclough RH. Effector mechanisms of myasthenic antibodies. Annals of the New York Academy of Sciences. 681: 264-73. PMID 8357166 DOI: 10.1111/J.1749-6632.1993.Tb22891.X  0.72
1991 Puckett C, Gomez CM, Korenberg JR, Tung H, Meier TJ, Chen XN, Hood L. Molecular cloning and chromosomal localization of one of the human glutamate receptor genes. Proceedings of the National Academy of Sciences of the United States of America. 88: 7557-61. PMID 1652753 DOI: 10.1073/Pnas.88.17.7557  0.72
1990 Gomez CM, Muggleton-Harris AL, Whittingham DG, Hood LE, Readhead C. Rapid preimplantation detection of mutant (shiverer) and normal alleles of the mouse myelin basic protein gene allowing selective implantation and birth of live young. Proceedings of the National Academy of Sciences of the United States of America. 87: 4481-4. PMID 1693773 DOI: 10.1073/Pnas.87.12.4481  0.72
1989 Hood L, Kumar V, Osman G, Beall SS, Gomez C, Funkhouser W, Kono DH, Nickerson D, Zaller DM, Urban JL. Autoimmune disease and T-cell immunologic recognition. Cold Spring Harbor Symposia On Quantitative Biology. 54: 859-74. PMID 2484250 DOI: 10.1101/Sqb.1989.054.01.100  0.72
1988 Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell. 54: 577-92. PMID 2456857 DOI: 10.1016/0092-8674(88)90079-7  0.72
1985 Corey AL, Richman DP, Shuman CA, Gomez CM, Arnason BG. Use of monoclonal antiacetylcholine receptor antibodies to investigate the macrophage inflammation of acute experimental myasthenia gravis: refractoriness to a second episode of acute disease. Neurology. 35: 1455-60. PMID 3875805 DOI: 10.1212/Wnl.35.10.1455  0.72
1985 Stefansson K, Dieperink ME, Richman DP, Gomez CM, Marton LS. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of Myasthenia gravis New England Journal of Medicine. 312: 221-225. PMID 2578213 DOI: 10.1056/Nejm198501243120407  0.72
1984 Gomez CM, Wollmann RL, Richman DP. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor. Acta Neuropathologica. 63: 131-43. PMID 6610275 DOI: 10.1007/Bf00697195  0.72
1982 Gomez CM, Richman DP. Anti-acetylcholine receptor antibodies directed against the α-bungarotoxin binding site induce a unique form of experimental myasthenia Proceedings of the National Academy of Sciences of the United States of America. 80: 4089-4093. PMID 6575398 DOI: 10.1073/Pnas.80.13.4089  0.72
1981 Gomez CM, Richman DP, Burres SA, Arnason BG, Berman PW, Fitch FW. Monoclonal hybridoma anti-acetylcholine receptor antibodies: antibody specificity and effect of passive transfer. Annals of the New York Academy of Sciences. 377: 97-109. PMID 6978667 DOI: 10.1111/J.1749-6632.1981.Tb33726.X  0.72
1981 Burres SA, Crayton JW, Gomez CM, Richman DP. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: Clinical and electrophysiological aspects Annals of Neurology. 9: 563-568. PMID 6167199 DOI: 10.1002/Ana.410090609  0.72
1980 Richman DP, Gomez CM, Berman PW, Burres SA, Fitch FW, Arnason BG. Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia. Nature. 286: 738-9. PMID 7412861 DOI: 10.1038/286738A0  0.72
1979 Gomez CM, Richman DP, Berman PW, Burres SA, Arnason BG, Fitch FW. Monoclonal antibodies against purified nicotinic acetylcholine receptor. Biochemical and Biophysical Research Communications. 88: 575-82. PMID 465055 DOI: 10.1016/0006-291X(79)92087-4  0.72
Show low-probability matches.